Business news – Page 58
-
BusinessNovo Nordisk to axe 1000 jobs
Diabetes specialist is cutting costs in the face of increased competition
-
BusinessAccidents prompt Chinese industry safety push
Government aims to close or relocate chemical plants to reduce incidents in populated areas
-
OpinionBooster shot
Zika and Ebola have highlighted the pharmaceutical industry’s ability to respond to critical needs
-
BusinessLanxess to buy Chemtura for additives
€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
-
BusinessPfizer scraps plans to split
Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
-
NewsPharma giants commit to tackling antimicrobial resistance
Plan to tackle superbugs includes changes to manufacturing and sales incentives
-
BusinessIneos lands first US shale gas in UK
Massive tankers create a ‘virtual pipeline’ bringing feedstock to replace dwindling domestic supplies
-
BusinessUS senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
ResearchWorld's first commercial MOF keeps fruit fresh
Packaging releases plant growth regulator that slows down ripening
-
BusinessAcquisition spree moves Allergan towards innovative drugs
Company acquires five companies in six weeks across three disease areas
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
OpinionSlimmer synthesis
Atom economy is a noble aim, but there are other routes to efficient molecule making
-
BusinessJ&J to buy Abbott Medical Optics
Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business
-
BusinessDanaher boosts diagnostics with Cepheid buyout
$4bn deal strengthens Danaher’s life sciences portfolio
-
NewsGlyphosate ‘not likely’ to be carcinogenic
US environmental agency issues finding that the herbicide is unlikely to cause cancer, months after accidentally posting report online
-
BusinessFDA’s first Duchenne drug approval reveals schism
Oligonucleotide drug reaches market amid pressure from patient families and strife over ‘patient-focused drug development’ at the regulator
-
BusinessFertiliser firms Agrium and PotashCorp to merge
Canadian combination will create one of the largest crop nutrient companies in the world.
-
BusinessBayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
BusinessAtanor chemical plant in Argentina shuttered
Toxic releases have led to the indefinite closure of the facility after a decade-long legal fight
-
BusinessBrexit could push Japanese pharma out of the UK
Warnings that Japanese R&D investment in the UK is endangered by plans to leave the EU